NEWwbztv-small wbz-am-small 985-small mytv38web2

Local

Waltham-based Alkermes Buying Irish Drug Company

By Anthony Silva, WBZ NewsRadio 1030
View Comments
(credit: AP)

(credit: AP)

420x316-grad-silva Anthony Silva
Anthony Silva is co-host of the WBZ Afternoon News heard each wee...
Read More

CBS Boston (con't)

Affordable Care Act Updates: CBSBoston.com/ACA

Health News & Information: CBSBoston.com/Health

Get Breaking News First

Receive News, Politics, and Entertainment Headlines Each Morning.
Sign Up
For The Guys

WALTHAM (CBS) — Local biopharmaceutical company Alkermes of Waltham is buying Elan Drug Technologies, a drug formulation company headquartered in Dublin, Ireland. The deal is valued at about $960 million in cash and stock.

Alkermes Chief Financial Officer Jim Frates says no job cuts are expected here as the companies plan to grow their current portfolio of products. He says the two operations in Waltham and Dublin as well as a plant in Ohio will complement one another.

Together, the companies already have about 25 drug products on world markets including products for alcohol and opioid dependence, schizophrenia, bipolar disorder, diabetes and chronic diseases.

Frates says with this purchase, the newly combined Alkermes will become immediately profitable.

WBZ NewsRadio 1030′s Anthony Silva talks with Alkermes’ Jim Frates


View Comments
blog comments powered by Disqus